Isoform | Protein Position | Transcript Position | Chromosomal Position (HG38) | Chromosomal Position (HG19) |
---|---|---|---|---|
IC | 155 | 688;689;690 | chr2:178800515;178800514;178800513 | chr2:179665242;179665241;179665240 |
N2AB | 155 | 688;689;690 | chr2:178800515;178800514;178800513 | chr2:179665242;179665241;179665240 |
N2A | 155 | 688;689;690 | chr2:178800515;178800514;178800513 | chr2:179665242;179665241;179665240 |
N2B | 155 | 688;689;690 | chr2:178800515;178800514;178800513 | chr2:179665242;179665241;179665240 |
Novex-1 | 155 | 688;689;690 | chr2:178800515;178800514;178800513 | chr2:179665242;179665241;179665240 |
Novex-2 | 155 | 688;689;690 | chr2:178800515;178800514;178800513 | chr2:179665242;179665241;179665240 |
Novex-3 | 155 | 688;689;690 | chr2:178800515;178800514;178800513 | chr2:179665242;179665241;179665240 |
SNV | RS | DUET |
PolyPhen-2 |
Condel |
Rhapsody |
REVEL |
MVP |
Source |
MAF |
Disease |
Zygosity |
Site annotation |
mCSM PPI |
Predicted PPI site |
Comments |
AFR |
AMR |
AMS |
ASJ |
EAS |
EUR |
FIN |
MDE |
NFE |
SAS |
OTH |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
E/Q | rs1429805491 | 0.676 | 0.623 | N | 0.35 | 0.205 | 0.266385636622 | gnomAD-2.1.1 | 3.98E-06 | None | None | None | -1.009(TCAP) | N | None | 0 | 0 | None | 0 | 0 | None | 3.27E-05 | None | 0 | 0 | 0 |
E/Q | rs1429805491 | 0.676 | 0.623 | N | 0.35 | 0.205 | 0.266385636622 | gnomAD-4.0.0 | 1.59045E-06 | None | None | None | -1.009(TCAP) | N | None | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 0 | 1.43271E-05 | 0 |
SAV |
AlphaMissense (IC) |
AlphaMissense Class (IC) |
AlphaMissense (N2AB) |
AlphaMissense Class (N2AB) |
mCSM |
mCSM class |
PolyPhen-2 |
PolyPhen-2 Class |
Rhapsody |
Rhapsody Class |
Condel |
Condel Score |
Site annotation |
mCSM PPI |
Predicted PPI site |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
E/A | 0.3041 | likely_benign | 0.3877 | ambiguous | -0.22 | Destabilizing | 0.38 | N | 0.393 | neutral | N | 0.504131086 | None | -0.276(TCAP) | N |
E/C | 0.9867 | likely_pathogenic | 0.9911 | pathogenic | 0.082 | Stabilizing | 0.985 | D | 0.411 | neutral | None | None | None | -0.242(TCAP) | N |
E/D | 0.2291 | likely_benign | 0.246 | benign | -0.175 | Destabilizing | None | N | 0.157 | neutral | N | 0.463312521 | None | -0.152(TCAP) | N |
E/F | 0.9524 | likely_pathogenic | 0.9671 | pathogenic | -0.2 | Destabilizing | 0.97 | D | 0.363 | neutral | None | None | None | -0.153(TCAP) | N |
E/G | 0.4418 | ambiguous | 0.5554 | ambiguous | -0.361 | Destabilizing | 0.672 | D | 0.388 | neutral | N | 0.516305462 | None | -0.441(TCAP) | N |
E/H | 0.8091 | likely_pathogenic | 0.8599 | pathogenic | 0.131 | Stabilizing | 0.885 | D | 0.305 | neutral | None | None | None | 0.497(TCAP) | N |
E/I | 0.7104 | likely_pathogenic | 0.7788 | pathogenic | 0.101 | Stabilizing | 0.834 | D | 0.372 | neutral | None | None | None | 0.213(TCAP) | N |
E/K | 0.3933 | ambiguous | 0.478 | ambiguous | 0.602 | Stabilizing | 0.532 | D | 0.398 | neutral | N | 0.499629298 | None | -0.019(TCAP) | N |
E/L | 0.8058 | likely_pathogenic | 0.8571 | pathogenic | 0.101 | Stabilizing | 0.834 | D | 0.368 | neutral | None | None | None | 0.213(TCAP) | N |
E/M | 0.8048 | likely_pathogenic | 0.8453 | pathogenic | 0.147 | Stabilizing | 0.912 | D | 0.379 | neutral | None | None | None | 0.902(TCAP) | N |
E/N | 0.5173 | ambiguous | 0.5868 | pathogenic | 0.269 | Stabilizing | 0.004 | N | 0.239 | neutral | None | None | None | -1.652(TCAP) | N |
E/P | 0.955 | likely_pathogenic | 0.973 | pathogenic | 0.012 | Stabilizing | 0.427 | N | 0.335 | neutral | None | None | None | 0.055(TCAP) | N |
E/Q | 0.2811 | likely_benign | 0.3286 | benign | 0.3 | Stabilizing | 0.623 | D | 0.35 | neutral | N | 0.513133156 | None | -1.009(TCAP) | N |
E/R | 0.5758 | likely_pathogenic | 0.6668 | pathogenic | 0.691 | Stabilizing | 0.915 | D | 0.304 | neutral | None | None | None | -0.127(TCAP) | N |
E/S | 0.3966 | ambiguous | 0.4744 | ambiguous | 0.158 | Stabilizing | 0.449 | N | 0.373 | neutral | None | None | None | -1.36(TCAP) | N |
E/T | 0.4252 | ambiguous | 0.5153 | ambiguous | 0.286 | Stabilizing | 0.529 | D | 0.404 | neutral | None | None | None | -1.176(TCAP) | N |
E/V | 0.4435 | ambiguous | 0.5244 | ambiguous | 0.012 | Stabilizing | 0.729 | D | 0.362 | neutral | D | 0.553055496 | None | 0.055(TCAP) | N |
E/W | 0.9841 | likely_pathogenic | 0.9896 | pathogenic | -0.097 | Destabilizing | 0.997 | D | 0.515 | neutral | None | None | None | -0.339(TCAP) | N |
E/Y | 0.9155 | likely_pathogenic | 0.939 | pathogenic | 0.036 | Stabilizing | 0.989 | D | 0.367 | neutral | None | None | None | -0.229(TCAP) | N |
Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.